RifZ (AMED_0655) Is a Pathway-Specific Regulator for Rifamycin Biosynthesis in Amycolatopsis mediterranei

Rifamycin and its derivatives are particularly effective against the pathogenic mycobacteria Mycobacterium tuberculosis and Mycobacterium leprae. Although the biosynthetic pathway of rifamycin has been extensively studied in Amycolatopsis mediterranei, little is known about the regulation in rifamyc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Appl Environ Microbiol
Autors principals: Li, Chen, Liu, Xinqiang, Lei, Chao, Yan, Han, Shao, Zhihui, Wang, Ying, Zhao, Guoping, Wang, Jin, Ding, Xiaoming
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Genetics and Molecular Biology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5377510/
https://ncbi.nlm.nih.gov/pubmed/28159794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AEM.03201-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars